Familial Hypertrophic Cardiomyopathy-Linked Mutant Troponin T Causes Stress-Induced Ventricular Tachycardia and Ca2+-Dependent Action Potential Remodeling-Reference-Cited by-同舟云学术

Familial Hypertrophic Cardiomyopathy-Linked Mutant Troponin T Causes Stress-Induced Ventricular Tachycardia and Ca2+-Dependent Action Potential Remodeling

Published:2003-03-07 Issue:4 Volume:92 Page:428-436
ISSN:0009-7330
Container-title:Circulation Research
language:en
Short-container-title:Circulation Research

Author:

Knollmann Björn C.¹,Kirchhof Paulus¹,Sirenko Syevda G.¹,Degen Hubertus¹,Greene Anne E.¹,Schober Tilmann¹,Mackow Jessica C.¹,Fabritz Larissa¹,Potter James D.¹,Morad Martin¹

Affiliation:

1. From the Department of Pharmacology (B.J.K., S.G.S., H.D., A.E.G., T.S., J.C.M., M.M.), Georgetown University Medical Center, Washington, DC; the Department of Cardiology and Angiology (P.K., L.F.), University Hospital Münster, Germany; and the Department of Molecular and Cellular Pharmacology (J.D.P.), University of Miami School of Medicine, Miami, Fla.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology

Reference26 articles.

1. The Molecular Genetic Basis for Hypertrophic Cardiomyopathy

2. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients

3. Magnitude of Left Ventricular Hypertrophy and Risk of Sudden Death in Hypertrophic Cardiomyopathy

4. Mutations in the Genes for Cardiac Troponin T and α-Tropomyosin in Hypertrophic Cardiomyopathy

5. Sudden Death due to Troponin T Mutations

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ent-Verticilide B1 Inhibits Type 2 Ryanodine Receptor Channels and is Antiarrhythmic inCasq2^−/−Mice;Molecular Pharmacology;2024-01-22

2. Mechanism of Ion Channel Impairment in the Occurrence of Arrhythmia in Patients with Hypertrophic Cardiomyopathy;Cardiology in Review;2023-10-09

3. New drug discovery of cardiac anti-arrhythmic drugs: insights in animal models;Scientific Reports;2023-09-29

4. Human engineered cardiac tissue model of hypertrophic cardiomyopathy recapitulates key hallmarks of the disease and the effect of chronic mavacamten treatment;Frontiers in Bioengineering and Biotechnology;2023-09-08

5. Mouse Models of Cardiomyopathies Caused by Mutations in Troponin C;International Journal of Molecular Sciences;2023-08-02